ID   KS6A6_HUMAN             Reviewed;         745 AA.
AC   Q9UK32; B2R854; B7ZL90; Q6FHX2; Q8WX28; Q9H4S6;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   15-MAR-2017, entry version 158.
DE   RecName: Full=Ribosomal protein S6 kinase alpha-6;
DE            Short=S6K-alpha-6;
DE            EC=2.7.11.1;
DE   AltName: Full=90 kDa ribosomal protein S6 kinase 6;
DE            Short=p90-RSK 6;
DE            Short=p90RSK6;
DE   AltName: Full=Ribosomal S6 kinase 4;
DE            Short=RSK-4;
DE   AltName: Full=pp90RSK4;
GN   Name=RPS6KA6; Synonyms=RSK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10644430; DOI=10.1006/geno.1999.6004;
RA   Yntema H.G., van den Helm B., Kissing J., van Duijnhoven G.,
RA   Poppelaars F., Chelly J., Moraine C., Fryns J.-P., Hamel B.C.J.,
RA   Heilbronner H., Pander H.-J., Brunner H.G., Ropers H.-H.,
RA   Cremers F.P.M., van Bokhoven H.;
RT   "A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in
RT   patients with complex X-linked mental retardation.";
RL   Genomics 62:332-343(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION IN P53/TP53 SIGNALING.
RX   PubMed=15042092; DOI=10.1038/nature02371;
RA   Berns K., Hijmans E.M., Mullenders J., Brummelkamp T.R., Velds A.,
RA   Heimerikx M., Kerkhoven R.M., Madiredjo M., Nijkamp W., Weigelt B.,
RA   Agami R., Ge W., Cavet G., Linsley P.S., Beijersbergen R.L.,
RA   Bernards R.;
RT   "A large-scale RNAi screen in human cells identifies new components of
RT   the p53 pathway.";
RL   Nature 428:431-437(2004).
RN   [8]
RP   FUNCTION, ENZYME REGULATION, INTERACTION WITH MAPK3, SUBCELLULAR
RP   LOCATION, PHOSPHORYLATION AT SER-232; SER-372; SER-389 AND THR-581,
RP   AND MUTAGENESIS OF SER-372; SER-389 AND THR-581.
RX   PubMed=15632195; DOI=10.1074/jbc.M408194200;
RA   Duemmler B.A., Hauge C., Silber J., Yntema H.G., Kruse L.S.,
RA   Kofoed B., Hemmings B.A., Alessi D.R., Froedin M.;
RT   "Functional characterization of human RSK4, a new 90-kDa ribosomal S6
RT   kinase, reveals constitutive activation in most cell types.";
RL   J. Biol. Chem. 280:13304-13314(2005).
RN   [9]
RP   REVIEW ON FUNCTION.
RX   PubMed=18813292; DOI=10.1038/nrm2509;
RA   Anjum R., Blenis J.;
RT   "The RSK family of kinases: emerging roles in cellular signalling.";
RL   Nat. Rev. Mol. Cell Biol. 9:747-758(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-140; THR-258 AND ASN-692.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Constitutively active serine/threonine-protein kinase
CC       that exhibits growth-factor-independent kinase activity and that
CC       may participate in p53/TP53-dependent cell growth arrest signaling
CC       and play an inhibitory role during embryogenesis.
CC       {ECO:0000269|PubMed:15042092, ECO:0000269|PubMed:15632195}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ENZYME REGULATION: Constitutively activated by phosphorylation at
CC       Ser-232, Ser-372, and Ser-389 in serum-starved cells. Does not
CC       require growth factor stimulation for significant kinase activity.
CC       {ECO:0000269|PubMed:15632195}.
CC   -!- SUBUNIT: Forms a complex with MAPK3/ERK1 but not with MAPK9 or
CC       MAPK14 in serum-starved cells.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:15632195}. Nucleus
CC       {ECO:0000269|PubMed:15632195}. Note=Predominantly cytosolic.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UK32-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UK32-2; Sequence=VSP_056181;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Phosphorylated at Ser-232, Ser-372, and Ser-389 in serum-
CC       starved cells. {ECO:0000269|PubMed:15632195}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. S6 kinase subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF184965; AAF13190.1; -; mRNA.
DR   EMBL; CR536566; CAG38803.1; -; mRNA.
DR   EMBL; AK313240; BAG36051.1; -; mRNA.
DR   EMBL; AL389887; CAC16111.2; -; Genomic_DNA.
DR   EMBL; AL354653; CAC16111.2; JOINED; Genomic_DNA.
DR   EMBL; AL354653; CAD13486.2; -; Genomic_DNA.
DR   EMBL; AL389887; CAD13486.2; JOINED; Genomic_DNA.
DR   EMBL; CH471104; EAW98575.1; -; Genomic_DNA.
DR   EMBL; BC143648; AAI43649.1; -; mRNA.
DR   CCDS; CCDS14451.1; -. [Q9UK32-1]
DR   CCDS; CCDS83480.1; -. [Q9UK32-2]
DR   RefSeq; NP_001317441.1; NM_001330512.1. [Q9UK32-2]
DR   RefSeq; NP_055311.1; NM_014496.4. [Q9UK32-1]
DR   RefSeq; XP_011529219.1; XM_011530917.2. [Q9UK32-2]
DR   UniGene; Hs.234478; -.
DR   ProteinModelPortal; Q9UK32; -.
DR   SMR; Q9UK32; -.
DR   BioGrid; 118144; 36.
DR   IntAct; Q9UK32; 29.
DR   MINT; MINT-1424416; -.
DR   STRING; 9606.ENSP00000262752; -.
DR   BindingDB; Q9UK32; -.
DR   ChEMBL; CHEMBL4924; -.
DR   GuidetoPHARMACOLOGY; 1530; -.
DR   iPTMnet; Q9UK32; -.
DR   PhosphoSitePlus; Q9UK32; -.
DR   BioMuta; RPS6KA6; -.
DR   DMDM; 11133131; -.
DR   EPD; Q9UK32; -.
DR   PaxDb; Q9UK32; -.
DR   PeptideAtlas; Q9UK32; -.
DR   PRIDE; Q9UK32; -.
DR   DNASU; 27330; -.
DR   Ensembl; ENST00000262752; ENSP00000262752; ENSG00000072133. [Q9UK32-1]
DR   Ensembl; ENST00000620340; ENSP00000483896; ENSG00000072133. [Q9UK32-2]
DR   GeneID; 27330; -.
DR   KEGG; hsa:27330; -.
DR   UCSC; uc004eej.3; human. [Q9UK32-1]
DR   CTD; 27330; -.
DR   DisGeNET; 27330; -.
DR   GeneCards; RPS6KA6; -.
DR   HGNC; HGNC:10435; RPS6KA6.
DR   HPA; HPA002852; -.
DR   HPA; HPA003904; -.
DR   MIM; 300303; gene.
DR   neXtProt; NX_Q9UK32; -.
DR   OpenTargets; ENSG00000072133; -.
DR   PharmGKB; PA34850; -.
DR   eggNOG; KOG0598; Eukaryota.
DR   eggNOG; ENOG410XNPH; LUCA.
DR   GeneTree; ENSGT00860000133668; -.
DR   HOGENOM; HOG000233033; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; Q9UK32; -.
DR   KO; K04373; -.
DR   OMA; YMDESAS; -.
DR   OrthoDB; EOG091G05Z7; -.
DR   PhylomeDB; Q9UK32; -.
DR   TreeFam; TF313438; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   Reactome; R-HSA-442742; CREB phosphorylation through the activation of Ras.
DR   Reactome; R-HSA-444257; RSK activation.
DR   SignaLink; Q9UK32; -.
DR   GenomeRNAi; 27330; -.
DR   PRO; PR:Q9UK32; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000072133; -.
DR   CleanEx; HS_RPS6KA6; -.
DR   Genevisible; Q9UK32; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; TAS:Reactome.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IMP:UniProtKB.
DR   GO; GO:0045992; P:negative regulation of embryonic development; ISS:UniProtKB.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:2000381; P:negative regulation of mesoderm development; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR016239; Ribosomal_S6_kinase_II.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 2.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000606; Ribsml_S6_kin_2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 2.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    745       Ribosomal protein S6 kinase alpha-6.
FT                                /FTId=PRO_0000086209.
FT   DOMAIN       73    330       Protein kinase 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      331    400       AGC-kinase C-terminal.
FT   DOMAIN      426    683       Protein kinase 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      79     87       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     432    440       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    198    198       Proton acceptor. {ECO:0000250}.
FT   ACT_SITE    543    543       Proton acceptor. {ECO:0000250}.
FT   BINDING     105    105       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING     455    455       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     232    232       Phosphoserine.
FT                                {ECO:0000269|PubMed:15632195}.
FT   MOD_RES     372    372       Phosphoserine.
FT                                {ECO:0000269|PubMed:15632195}.
FT   MOD_RES     389    389       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:15632195}.
FT   MOD_RES     581    581       Phosphothreonine.
FT                                {ECO:0000269|PubMed:15632195}.
FT   VAR_SEQ       1     27       MLPFAPQDEPWDREMEVFSGGGASSGE -> MGLSTSAIWK
FT                                NTRVEIVNPYEVKRKVK (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056181.
FT   VARIANT     140    140       Y -> C (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040637.
FT   VARIANT     258    258       S -> T (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040638.
FT   VARIANT     692    692       D -> N (in dbSNP:rs6616890).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_030670.
FT   MUTAGEN     372    372       S->A: No effect on activity.
FT                                {ECO:0000269|PubMed:15632195}.
FT   MUTAGEN     389    389       S->A: Strongly decreases activity.
FT                                {ECO:0000269|PubMed:15632195}.
FT   MUTAGEN     581    581       T->A: No effect on activity.
FT                                {ECO:0000269|PubMed:15632195}.
FT   CONFLICT    116    116       D -> G (in Ref. 2; CAG38803).
FT                                {ECO:0000305}.
FT   CONFLICT    295    295       F -> L (in Ref. 2; CAG38803).
FT                                {ECO:0000305}.
FT   CONFLICT    341    341       R -> G (in Ref. 2; CAG38803).
FT                                {ECO:0000305}.
SQ   SEQUENCE   745 AA;  83872 MW;  5EC5AB2FA1C19DE8 CRC64;
     MLPFAPQDEP WDREMEVFSG GGASSGEVNG LKMVDEPMEE GEADSCHDEG VVKEIPITHH
     VKEGYEKADP AQFELLKVLG QGSFGKVFLV RKKTGPDAGQ LYAMKVLKKA SLKVRDRVRT
     KMERDILVEV NHPFIVKLHY AFQTEGKLYL ILDFLRGGDV FTRLSKEVLF TEEDVKFYLA
     ELALALDHLH QLGIVYRDLK PENILLDEIG HIKLTDFGLS KESVDQEKKA YSFCGTVEYM
     APEVVNRRGH SQSADWWSYG VLMFEMLTGT LPFQGKDRNE TMNMILKAKL GMPQFLSAEA
     QSLLRMLFKR NPANRLGSEG VEEIKRHLFF ANIDWDKLYK REVQPPFKPA SGKPDDTFCF
     DPEFTAKTPK DSPGLPASAN AHQLFKGFSF VATSIAEEYK ITPITSANVL PIVQINGNAA
     QFGEVYELKE DIGVGSYSVC KRCIHATTNM EFAVKIIDKS KRDPSEEIEI LMRYGQHPNI
     ITLKDVFDDG RYVYLVTDLM KGGELLDRIL KQKCFSEREA SDILYVISKT VDYLHCQGVV
     HRDLKPSNIL YMDESASADS IRICDFGFAK QLRGENGLLL TPCYTANFVA PEVLMQQGYD
     AACDIWSLGV LFYTMLAGYT PFANGPNDTP EEILLRIGNG KFSLSGGNWD NISDGAKDLL
     SHMLHMDPHQ RYTAEQILKH SWITHRDQLP NDQPKRNDVS HVVKGAMVAT YSALTHKTFQ
     PVLEPVAASS LAQRRSMKKR TSTGL
//
